Skip to content

Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial

Acupuncture for Functional Bowel Disease

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01350570
Enrollment
449
Registered
2011-05-10
Start date
2011-08-31
Completion date
2014-09-30
Last updated
2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea-predominant Irritable Bowel Syndrome, Functional Diarrhea

Keywords

acupuncture, loperamide, functional diarrhea, IBS

Brief summary

This trial is to assess the effectiveness of three types of acupuncture for patients with functional diarrhea comparing to a positive drug control.

Detailed description

Outcome measurements: The frequency of bowel movement; The bristol stool scale; SF-36 evaluation

Interventions

OTHERacupuncture

acupuncture group1, acupoints ST25 and BL25 will be used in this trial.

OTHERacupuncture group2

Acupoints LI11 and ST37 will be used in this group. LI11 is located at upper limb while ST37 is located at the lower limb.

OTHERacupuncture group3

All acupoints used in acupuncture group1 and group2 will be used in this group.

DRUGLoperamide

Loperamide will be used in this group for a dose of 2mg a time, three time a day.

Sponsors

Guang'anmen Hospital of China Academy of Chinese Medical Sciences
CollaboratorOTHER
Chengdu University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed as diarrhoea-predominant irritable bowel syndrome according to Rome III criteria; 2. Age between 18 and 65 years old; 3. Did not take any medicine for bowel symptoms and attend other clinical research; 4. Have inform consent signed.

Exclusion criteria

1. Diarrhea caused by diseases such as infection, etc. 2. Patients can't express himself clearly or with mental diseases; 3. Tumor and other infectious diseases; 4. With other serious diseases of Cardiovascular, liver, kidney, digestive or blood system; Pregnant women or planned to be pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Average weekly stool frequency4th week after inclusionAverage weekly stool frequency, change from baseline in 4 weeks

Secondary

MeasureTime frameDescription
Assessment score of Bristol stool scale4th and 8th week after inclusionBristol stool scale was designed to classify the human stool into 7 categories. The seven types of stool are: Type 1: Separate hard lumps, like nuts (hard to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft Type 5: Soft blobs with clear cut edges (passed easily) Type 6: Fluffy pieces with ragged edges, a mushy stool Type 7: Watery, no solid pieces. Entirely liquid
Assessment score of SF-36 scale4th and 8th after inclusionThe Short Form (36) Health Survey (SF-36) is a survey of patient health. The SF-36 is commonly used in health economics as a variable in the quality-adjusted life year calculation to determine the cost-effectiveness of a health treatment. The chinese version of SF-36 was validated and has been widely used in acupuncture studies.
Number of patients with adverse events after treatment4th week after inclusionNumber of patients with adverse events after treatment will be recorded and compared among three groups.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026